{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T09:14:26Z","timestamp":1720775666460},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,25]],"date-time":"2015-05-25T00:00:00Z","timestamp":1432512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijcha-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ijcha.2015.05.010","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T00:29:12Z","timestamp":1432945752000},"page":"87-94","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model"],"prefix":"10.1016","volume":"8","author":[{"given":"Felix W.","family":"Friedrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannieh","family":"Sotoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Geertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Flenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Reischmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Eschenhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"El-Armouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcha.2015.05.010_bb0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.ijcha.2015.05.010_bb0010","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2174\/1389201011208062467","article-title":"Genetics of hypertrophic and dilated cardiomyopathy","volume":"13","author":"Friedrich","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.ijcha.2015.05.010_bb0015","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1038\/ncomms6515","article-title":"Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice","volume":"5","author":"Mearini","year":"2014","journal-title":"Nat Commun."},{"issue":"6","key":"10.1016\/j.ijcha.2015.05.010_bb0020","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/0735-1097(93)90591-N","article-title":"Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography","volume":"22","author":"Lefroy","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ijcha.2015.05.010_bb0025","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/S0735-1097(00)00626-4","article-title":"Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy","volume":"35","author":"Li","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ijcha.2015.05.010_bb0030","first-page":"487","article-title":"Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy","volume":"44","author":"Sipola","year":"2003","journal-title":"J Nucl Med Allied Sci"},{"issue":"25","key":"10.1016\/j.ijcha.2015.05.010_bb0035","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.jacc.2011.06.011","volume":"58","author":"Gersh","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"10.1016\/j.ijcha.2015.05.010_bb0040","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.ijcha.2015.05.010_bb0045","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/eurheartj\/ehs150","article-title":"Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence","volume":"33","author":"Spoladore","year":"2012","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ijcha.2015.05.010_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1152\/physrev.2000.80.1.173","article-title":"Effects of serine\/threonine protein phosphatases on ion channels in excitable membranes","volume":"80","author":"Herzig","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ijcha.2015.05.010_bb0055","doi-asserted-by":"crossref","first-page":"D961","DOI":"10.2741\/A336","article-title":"Physiologic importance of protein phosphatase inhibitors","volume":"3","author":"Oliver","year":"1998","journal-title":"Front Biosci"},{"issue":"3","key":"10.1016\/j.ijcha.2015.05.010_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.yjmcc.2009.05.010","article-title":"Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology","volume":"47","author":"Nicolaou","year":"2009","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.ijcha.2015.05.010_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1096\/fj.02-0057fje","article-title":"Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes","volume":"17","author":"El-Armouche","year":"2003","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.ijcha.2015.05.010_bb0070","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/CIRCRESAHA.108.189811","article-title":"Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia\/reperfusion injury","volume":"104","author":"Nicolaou","year":"2009","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ijcha.2015.05.010_bb0075","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/mt.2014.127","article-title":"Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure","volume":"22","author":"Ishikawa","year":"2014","journal-title":"Mol Ther"},{"issue":"3","key":"10.1016\/j.ijcha.2015.05.010_bb0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cvr\/cvn208","article-title":"Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy","volume":"80","author":"El-Armouche","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ijcha.2015.05.010_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10741-008-9132-8","article-title":"Beta-adrenergic stimulation and myocardial function in the failing heart","volume":"14","author":"El-Armouche","year":"2009","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10.1016\/j.ijcha.2015.05.010_bb0090","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cvr\/cvv025","article-title":"Genetic advances in sarcomeric cardiomyopathies: state of the art","volume":"105","author":"Ho","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ijcha.2015.05.010_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardiores.2004.04.009","article-title":"Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice","volume":"63","author":"Carrier","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ijcha.2015.05.010_bb0100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardiores.2005.11.009","article-title":"Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice","volume":"69","author":"Cazorla","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10.1016\/j.ijcha.2015.05.010_bb0105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCRESAHA.107.158774","article-title":"Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes","volume":"101","author":"Pohlmann","year":"2007","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ijcha.2015.05.010_bb0110","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1523\/JNEUROSCI.20-10-03537.2000","article-title":"Protein phosphatase-1 regulation in the induction of long-term potentiation: heterogeneous molecular mechanisms","volume":"20","author":"Allen","year":"2000","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.ijcha.2015.05.010_bb0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","article-title":"Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice","volume":"52","author":"Fraysse","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.ijcha.2015.05.010_bb0120","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00395-014-0451-8","article-title":"FHL2 expression and variants in hypertrophic cardiomyopathy","volume":"109","author":"Friedrich","year":"2014","journal-title":"Basic Res Cardiol"},{"issue":"14","key":"10.1016\/j.ijcha.2015.05.010_bb0125","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1093\/hmg\/dds157","article-title":"Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy","volume":"21","author":"Friedrich","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.ijcha.2015.05.010_bb0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yjmcc.2007.05.003","article-title":"Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure","volume":"43","author":"El-Armouche","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"11","key":"10.1016\/j.ijcha.2015.05.010_bb0135","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ejheart.2007.09.006","article-title":"Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart","volume":"9","author":"El-Armouche","year":"2007","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ijcha.2015.05.010_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cardiores.2003.11.005","article-title":"Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts","volume":"61","author":"El-Armouche","year":"2004","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.ijcha.2015.05.010_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-011-0235-3","article-title":"Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy","volume":"107","author":"Schlossarek","year":"2012","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"10.1016\/j.ijcha.2015.05.010_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10974-011-9273-6","article-title":"Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice","volume":"33","author":"Schlossarek","year":"2012","journal-title":"J Muscle Res Cell Motil"},{"issue":"21","key":"10.1016\/j.ijcha.2015.05.010_bb0155","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0195-668X(03)00479-2","volume":"24","author":"Maron","year":"2003","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ijcha.2015.05.010_bb0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJM199703133361107","article-title":"The management of hypertrophic cardiomyopathy","volume":"336","author":"Spirito","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijcha.2015.05.010_bb0165","first-page":"194","article-title":"Contemporary treatment of hypertrophic cardiomyopathy","volume":"36","author":"Marian","year":"2009","journal-title":"Tex Heart Inst J"},{"issue":"10","key":"10.1016\/j.ijcha.2015.05.010_bb0170","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: a systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ijcha.2015.05.010_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcha.2015.05.010_bb0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12265-009-9132-7","article-title":"Experimental therapies in hypertrophic cardiomyopathy","volume":"2","author":"Marian","year":"2009","journal-title":"J Cardiovasc Transl Res"},{"issue":"11","key":"10.1016\/j.ijcha.2015.05.010_bb0185","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1172\/JCI11093","article-title":"An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy","volume":"106","author":"Fatkin","year":"2000","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ijcha.2015.05.010_bb0190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model","volume":"109","author":"Semsarian","year":"2002","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.ijcha.2015.05.010_bb0195","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000121426.43044.2B","article-title":"Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy","volume":"109","author":"Tsybouleva","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2015.05.010_bb0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCGENETICS.113.000324","article-title":"Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins","volume":"7","author":"Alves","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"10.1016\/j.ijcha.2015.05.010_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00424-013-1409-7","article-title":"MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction","volume":"466","author":"Behrens-Gawlik","year":"2014","journal-title":"Pflugers Arch"},{"issue":"7","key":"10.1016\/j.ijcha.2015.05.010_bb0210","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/emmm.201202168","article-title":"Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice","volume":"5","author":"Gedicke-Hornung","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ijcha.2015.05.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.31","article-title":"Repair of Mybpc3 mRNA by 5\u2032-trans-splicing in a mouse model of hypertrophic cardiomyopathy","volume":"2","author":"Mearini","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"issue":"5","key":"10.1016\/j.ijcha.2015.05.010_bb0220","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejheart.2005.07.002","article-title":"Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice","volume":"7","author":"McMurray","year":"2005","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.ijcha.2015.05.010_bb0225","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1017\/S1047951113001030","article-title":"Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients","volume":"24","author":"El-Saiedi","year":"2014","journal-title":"Cardiol Young"},{"issue":"22","key":"10.1016\/j.ijcha.2015.05.010_bb0230","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/ajmg.a.31981","article-title":"Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy","volume":"143A","author":"Xin","year":"2007","journal-title":"Am J Med Genet A"}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906715300026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906715300026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T21:02:54Z","timestamp":1566766974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906715300026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":46,"alternative-id":["S2352906715300026"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2015.05.010","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2015.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}